Healthcare Market Research Reports and Trends

  Rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. The  osteoarthritis therapeutics market  is estimated at $6.8 billion in 2019 and projected to reach $10.1 billion by 2024 at a CAGR of 8.1 percent from 2019 to 2024. Osteoarthritis Therapeutics Market by Anatomy (Knee, Hip), Drug Type (NSAIDs, Corticosteroids), Route of Administration (Parenteral, Topical), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs). This growth, the report says, is in part due to the rapid increase in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Knee segment to witness the highest growth during the forecast period Based on anatomy, the market is segmented into knee...

  Rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. The report says, is in part due to the rapid increase in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease.  The  osteoarthritis therapeutics market  is estimated at $6.8 billion in 2019 and projected to reach $10.1 billion by 2024 at a CAGR of 8.1 percent from 2019 to 2024.  Knee segment to witness the highest growth during the forecast period The market is segmented into knee, hip, hand, and small-joint. The knee osteoarthritis segment accounted for the largest market share in 2018 and is expected to register the highest CAGR during the forecast period. This is attributed to a large number of patients s...

  According to the new market research report by MarketsandMarkets, the   osteoarthritis therapeutics market   is estimated at $ 6.8 billion  in 2019 and projected to reach  $10.1 billion  by 2024 at a CAGR of 8.1 percent from 2019 to 2024.  This growth, the report says, is in part due to the rapid increase in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209565994 Knee segment to witness the highest growth during the forecast period Based on anatomy, the market is segmented into knee, hip, hand, and small-joint. The k...

Significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. The  osteoarthritis therapeutics market  is expected to grow from USD 6.8 billion in 2019 to reach USD 10.1 billion by 2024, at a CAGR of 8.1%. Knee segment to witness the highest growth during the forecast period Based on anatomy, the market is segmented into knee, hip, hand, and small-joint. The knee osteoarthritis segment accounted for the largest market share in 2018 and is expected to register the highest CAGR during the forecast period. This is attributed to a large number of patients suffering from knee osteoarthritis. Viscosupplementation agents segment to dominate the osteoarthritis therapeutics market in 2018 Based on drug type, the market is segmented into viscosupplement...

Rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. The  osteoarthritis therapeutics market  is expected to grow from USD 6.8 billion in 2019 to reach USD 10.1 billion by 2024, at a CAGR of 8.1%. Knee segment to witness the highest growth during the forecast period Based on anatomy, the market is segmented into knee, hip, hand, and small-joint. The knee osteoarthritis segment accounted for the largest market share in 2018 and is expected to register the highest CAGR during the forecast period. This is attributed to a large number of patients suffering from knee osteoarthritis. Download PDF Brochure on Osteoarthritis Therapeutics Market Viscosupplementation agents segment to dominate the osteoarthritis therapeutics market in 2018 Based on drug type...